Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Disability, Quality of Life, and Pain Coping in Pediatric Migraine: An Observational Study.

Orr SL, Christie SN, Akiki S, McMillan HJ.

J Child Neurol. 2017 Jul;32(8):717-724. doi: 10.1177/0883073817702025. Epub 2017 Apr 9.

PMID:
28393667
2.

TOXOPLASMA SEROPREVALANCE IN NORTHERN IRELAND.

McCaughey C, Watt AP, McCaughey KA, Feeney MA, Coyle PV, Christie SN.

Ulster Med J. 2017 Jan;86(1):43-44. No abstract available.

3.

The Non-Inferiority Margins in Migraine Research (NIMM) Survey.

Orr SL, Ramsay T, Christie SN, Dodick D, Gladstone J, Dowlatshahi D.

Headache. 2017 May;57(5):729-736. doi: 10.1111/head.13048. Epub 2017 Feb 11.

PMID:
28188613
4.

Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings.

Orr SL, Aubé M, Becker WJ, Davenport WJ, Dilli E, Dodick D, Giammarco R, Gladstone J, Leroux E, Pim H, Dickinson G, Christie SN.

Cephalalgia. 2015 Mar;35(3):271-84. doi: 10.1177/0333102414535997. Epub 2014 May 29. Review.

PMID:
24875925
5.

Canadian Headache Society Guideline: acute drug therapy for migraine headache.

Worthington I, Pringsheim T, Gawel MJ, Gladstone J, Cooper P, Dilli E, Aube M, Leroux E, Becker WJ; Canadian Headache Society Acute Migraine Treatment Guideline Development Group.

Can J Neurol Sci. 2013 Sep;40(5 Suppl 3):S1-S80. Review.

PMID:
23968886
6.

Canadian Headache Society guideline for migraine prophylaxis.

Pringsheim T, Davenport W, Mackie G, Worthington I, Aubé M, Christie SN, Gladstone J, Becker WJ; Canadian Headache Society Prophylactic Guidelines Development Group.

Can J Neurol Sci. 2012 Mar;39(2 Suppl 2):S1-59.

PMID:
22683887
7.

Botulinum toxin type A and acute drug costs in migraine with triptan overuse.

Christie SN, Giammarco R, Gawel M, Mackie G, Gladstone J, Becker WJ.

Can J Neurol Sci. 2010 Sep;37(5):588-94.

PMID:
21059503
8.

Consensus statement: the development of a national Canadian Migraine Strategy.

Becker WJ, Christie SN, Mackie G, Cooper P; Canadian Headache Society Migraine Strategy Task Force.

Can J Neurol Sci. 2010 Jul;37(4):449-56.

PMID:
20724251
9.

Respiratory viral infection in lower airways of asymptomatic children.

Thavagnanam S, Christie SN, Doherty GM, Coyle PV, Shields MD, Heaney LG.

Acta Paediatr. 2010 Mar;99(3):394-8. doi: 10.1111/j.1651-2227.2009.01627.x. Epub 2009 Dec 9.

PMID:
20003105
10.

HIT-6 and MIDAS as measures of headache disability in a headache referral population.

Sauro KM, Rose MS, Becker WJ, Christie SN, Giammarco R, Mackie GF, Eloff AG, Gawel MJ.

Headache. 2010 Mar;50(3):383-95. doi: 10.1111/j.1526-4610.2009.01544.x. Epub 2009 Oct 8.

PMID:
19817883
11.

GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.

Goodman AD, Rossman H, Bar-Or A, Miller A, Miller DH, Schmierer K, Lublin F, Khan O, Bormann NM, Yang M, Panzara MA, Sandrock AW; GLANCE Investigators.

Neurology. 2009 Mar 3;72(9):806-12. doi: 10.1212/01.wnl.0000343880.13764.69.

12.

Respiratory viral infection in exacerbations of COPD.

McManus TE, Marley AM, Baxter N, Christie SN, O'Neill HJ, Elborn JS, Coyle PV, Kidney JC.

Respir Med. 2008 Nov;102(11):1575-80. doi: 10.1016/j.rmed.2008.06.006. Epub 2008 Jul 30.

13.

A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.

Wentz AL, Jimenez TB, Dixon RM, Aurora SK, Gold M; CXA20008 Study Investigators.

Eur J Neurol. 2008 Apr;15(4):420-7. doi: 10.1111/j.1468-1331.2008.02093.x. Epub 2008 Feb 26.

PMID:
18312401
14.

High levels of Epstein-Barr virus in COPD.

McManus TE, Marley AM, Baxter N, Christie SN, Elborn JS, O'Neill HJ, Coyle PV, Kidney JC.

Eur Respir J. 2008 Jun;31(6):1221-6. doi: 10.1183/09031936.00107507. Epub 2008 Feb 20.

15.

Migraine treatment.

Becker WJ, Gawel M, Mackie G, South V, Christie SN.

Can J Neurol Sci. 2007 Nov;34(4):S10-9. Review.

PMID:
18062466
16.

Acute and latent adenovirus in COPD.

McManus TE, Marley AM, Baxter N, Christie SN, Elborn JS, Heaney LG, Coyle PV, Kidney JC.

Respir Med. 2007 Oct;101(10):2084-90. Epub 2007 Jul 13.

17.

Topiramate prophylaxis and response to triptan treatment for acute migraine.

Becker WJ, Christie SN, Ledoux S, Binder C.

Headache. 2006 Oct;46(9):1424-30. Review.

PMID:
17040339
18.

Demographics and clinical features of patients referred to headache specialists.

Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, Eloff AG, Magnusson JE.

Can J Neurol Sci. 2006 May;33(2):228-34.

PMID:
16736736
19.

Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.

Jelinski SE, Becker WJ, Christie SN, Giammarco R, Mackie GF, Gawel MJ, Eloff AG, Magnusson JE.

Cephalalgia. 2006 May;26(5):578-88.

PMID:
16674767
20.

Pain free efficacy of sumatriptan in the early treatment of migraine.

Jelinski SE, Becker WJ, Christie SN, Ahmad FE, Pryse-Phillips W, Simpson SD.

Can J Neurol Sci. 2006 Feb;33(1):73-9.

PMID:
16583726

Supplemental Content

Loading ...
Support Center